1. Home
  2. BNGO vs GDTC Comparison

BNGO vs GDTC Comparison

Compare BNGO & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.16

Market Cap

11.6M

Sector

Industrials

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

N/A

Current Price

$1.03

Market Cap

12.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BNGO
GDTC
Founded
2003
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.6M
12.4M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
BNGO
GDTC
Price
$1.16
$1.03
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$6.33
N/A
AVG Volume (30 Days)
257.0K
11.5K
Earning Date
03-23-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
94.50
N/A
EPS
N/A
N/A
Revenue
$12,000,735.00
N/A
Revenue This Year
$25.49
$5.37
Revenue Next Year
$48.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
26.26
N/A
52 Week Low
$1.06
$0.73
52 Week High
$5.50
$3.68

Technical Indicators

Market Signals
Indicator
BNGO
GDTC
Relative Strength Index (RSI) 47.01 45.91
Support Level $1.07 $0.96
Resistance Level $1.18 $1.11
Average True Range (ATR) 0.07 0.06
MACD 0.01 0.00
Stochastic Oscillator 13.51 45.13

Price Performance

Historical Comparison
BNGO
GDTC

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: